NASDAQ (USD): Sangamo Therapeutics, Inc. (SGMO)
Last Price
2.17
Today's Change
-0.27 (11.06%)
Day's Change
2.09 - 2.54
Trading Volume
5,942,450
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Trump in Phone Call Advised Putin Not to Escalate in Ukraine — Washington Post
2
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
3
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
4
Hedge Funds Shorting Tesla Just Lost More Than US$5 Bil
5
Trump Seeks Fast Appointments; Elon Musk Makes Endorsement for Senate Leadership
#
Stock
Score
MSTR
MicroStrategy Incorporated
AGN
833
BABA
Alibaba Group Holding Limited
666
KXIN
Kaixin Auto Holdings
BITF
Bitfarms Ltd.
6
AAPL
Apple Inc.
500
7
PLTR
Palantir Technologies Inc.
466
8
CHMT
333
9
UEIC
Universal Electronics Inc.
10
NOC
Northrop Grumman Corporation
Last
Change
Volume
ELAB
0.027
+0.002
1,662,172,695
XTIA
0.063
+0.005
333,932,013
MTEM
0.622
+0.30
294,042,635
SVMH
0.028
+0.004
229,787,662
QUBT
4.05
+1.39
200,987,537
UAVS
3.19
+1.58
158,858,599
MVST
0.764
-0.032
158,643,688
NVDA
146.66
+0.39
126,468,933
LMDX
0.016
-0.018
120,553,903
NVR
9,207.30
+101.63
9,435
MKL
1,705.66
+50.30
34,236
DDS
433.94
+45.43
143,777
BH-A
1,050.00
+33.00
972
ASML
699.45
+26.04
3,059,044
BLK
1,048.569
+17.59
493,507
SPOT
482.63
+15.26
3,626,572
CYBR
305.70
+14.09
566,015
FSLR
191.92
+9.79
2,398,641
337.30
+8.92
19,395,342
BRK-A
701,755.76
-494.25
1,198
MELI
1,774.05
-343.25
2,940,447
1,309.00
-138.99
2,237,917
1,395.13
-102.30
318,280
TDG
1,270.87
-92.13
357,073
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....